Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Interest of the Dosage of CA 15-3 in CSF for Diagnosing Carcinomatous Meningitis in Breast Cancer

NCT00938756 is registered in ClinicalTrials.gov with Centre Oscar Lambret as lead sponsor.

NCT NCT00938756
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00938756 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Interest of the Dosage of CA 15-3 in CSF for Diagnosing Carcinomatous Meningitis in Breast Cancer
Lead sponsor
Centre Oscar Lambret
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2008
Completion date
Not reported
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, breast cancer, metastatic cancer